Latest Breaking News On - Phalcon nerd 301 - Page 1 : comparemela.com

The NDA submission was supported by positive data from the phase 3 PHALCON-NERD-301 study and has been assigned a standard 10-month review with a PDUFA target action date of July 19, 2024.

Azmi nabulsiDrug administrationPhathom pharmaceuticals announces positive toplinePhathom pharmaceuticalsPhathom pharmaceuticals announcesPhathom pharmaceuticals announces vonoprazanPhathom pharmaceuticalPrescription drug user fee actNew drug applicationTablets new drug applicationHeartburn associatedEvaluating daily dosingNon erosive gerdGastroesophageal reflux diseasePhalcon nerd 301Phase 3